Studies in follow-up or completed

The Hope Clinic has successfully completed recruitment in a number of vaccines studies related to HIV, HPV, influenza, yellow fever, and even ebola.  Below is a list of some of these.

HVTN Studies in Follow Up

HVTN 910 A clinical trial to assess the persistance of HIV vaccine-induced seropositivity (VISP) in participants who received a vaccine in a DAIDS funded preventive HIV vaccine trial. This study allows participants to have two HIV tests per year until they have three consecutive test results that show no vaccine-induced antibodies to HIV. To participate contact gosinsk@emory.edu or call 404-712-1370.

HIV vaccine-induced antibodies

The purpose of this study is to describe how long vaccine-induced antibodies to HIV persist in participants who have received preventive HIV vaccines.
  • Looking for participants from DAIDS-funded HIV preventive vaccine clinical trials that:
    • Received trial vaccine
    • Are HIV-uninfected
    • Test positive for vaccine-induced HIV Abs
  • 2 visits per year

HVTN 117

Janssen Study 118 A clinical research study being conducted to determine the safety and effectiveness of an investigational vaccine for the prevention of HIV. You may qualify if you are a healthy adult between the ages of 18 - 50 and are HIV negative. To participate, contact April Ross at aross9@emory.edu or call 404-712-9493

HVTN 119 (HIV Vaccine Clinical Trials Network) A clinical research study being conducted in Atlanta to determine the safety and effectiveness of an investigational vaccine for the prevention of HIV. You may qualify if you are a healthy adult between the ages of 22 - 50 and are HIV negative. Compensation is

provided to volunteers for their time and travel. To participate, contact April Ross at aross9@emory.edu or call 404-712-9493.

HVTN 120 (HIV Vaccine Clinical Trials Network)  A clinical research study in Atlanta to evaluate the safety and tolerability of an experimental HIV vaccine. You may qualify if you are a healthy adult between the ages of 22 - 40 and are HIV negative. Compensation is $25 for a screen visit, $75 to $125 (depending on the type of visit) for each of the remaining 11 visits. To participate, contact April Ross at aross9@emory.edu or call 404-712-9493.

HVTN 124 A clinical trial research study investigating 2 experimental vaccines against HIV. One of them is a DNA vaccine. The DNA in the vaccine tells the body to make 5 proteins that are similar to proteins from HIV. The second vaccine is a protein vaccine. The vaccine is made of 4 man-made proteins that match 4 of the proteins the body makes from the DNA vaccine. In this study, the protein vaccine also includes an adjuvant called GLA-SE. An adjuvant is a substance used to increase the body’s responses to a vaccine.

Studies Closed

HVTN 098 

HVTN 110

HVTN 505

HPTN Studies in Follow Up

Amp 

AMP Study: Antibody Mediated Study (Closed) A clinical trial research study to investigate the usefulness of an antibody to prevent HIV among non-HIV infected adults at risk of HIV-infection. To learn more, click here. To participate, contact our recruiters, Ms. April Ross or Mr. Rameses Frederick at aross9@emory.edu or rameses.frederick@emory.edu.

083 (Infiniti)

The infinity study evaluates whether Cabotegravir (CAB), an investigational new drug is as safe and works as well as FDA-Approved Truvada (Pre-exposure prophylasis or PrEP) in protecting individuals with high sexual exposure from acquiring HIV.  PrEP is an anti-HIV medication taken once daily that keeps HIV negative people from becoming infected with HIV.

VTEU Studies Closed

Norovirus Study  is a research study in Atlanta being done to determine the safety and tolerability of the Snow Mountain Virus (SMV) and the number of norovirus particles needed to make a person sick. We are looking for healthy adults, 18-49, who are willing and available to be in the hospital for 5 days. Noroviruses are the most common cause of gastroenteritis (stomach flu). You will be hospitalized for 5 days and have 4 follow-up visits and one phone call at 6 months. Compensation is $50 for initial screening, $200 per hospital day, $75 for follow up visits. If interested please call Eileen Osinski at 404-712-1371 or email at gosinsk@emory.edu.

H7N9 study involves 2 H7N9 vaccination visits. You may be eligible if you are a healthy adult 19 or older, live in the greater Atlanta area and are available for 7 clinic visits and 5 telephone calls over 13 months. Compensation is provided for all study visits. If interested please call Eileen Osinski at 404-712-1371 or email at gosinsk@emory.edu.

VAX2 004 A Chicken Pox Vaccine Immunology clinical research study recruting volunteers in the greater Atlanta area. We are looking for healthy volunteers over the age of 18 with proof of prior chicken pox vaccination. The study involves 1 to 2 clinic visits, blood draw and an optional bone marrow aspiration. You will be compensated for time and travel. If interested please call Eileen Osinski at 404-712-1371 or email at gosinsk@emory.edu.

Zika Natural History Study A clinical trial research study in Atlanta to better understand the effects of the Zika virus on the body. This information can be used to help develop a vaccine as well as better diagnostic and therapeutic tools in the future. No treatment or drugs will be given in this study. Volunteers with suspected or confirmed zika virus infection are needed for to participate in this study. Compensation is provided for time and travel. To participate, contact gosinsk@emory.edu or call 404-712-1370.

Cdiff study: Cdiffense Clostridium Difficile Vaccine Trial (Closed) A clinical trial research study to investigate a vaccine against the clostridium difficile "C. diff" among adults age 50 years or order. C Diff is a disease common among recently hospitalized individuals, particularly those of older age. Compensation is provided for all study visits. To participate, contact April Ross at aross9@emory.edu

Micro Biome Study A new clincial trial research study in need of volunteers who are willing to donate a stool sample. You must be in good health and between the ages of 18-23 or 60 and above. This research study involves 1-2 clinic visits and you are compensated for your participation. For more information please contact April Ross at aross9@emory.edu.

Influenza Heavy Water Study  A clinical trial research study to investigate the immune responses to the seasonal flu vaccine and to track the responses using a special water called heavy water. Participants must be between the ages of 18-45 and can not have had the flu shot in the past three years. Contact April Ross aross9@emory.edu for more information.